Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome
- PMID: 26138630
- PMCID: PMC4681683
- DOI: 10.1016/j.jcrc.2015.06.003
Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome
Erratum in
-
Corrigendum to: "Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome" [J Crit Care 2015;30(5):994-997].J Crit Care. 2015 Dec;30(6):1421. doi: 10.1016/j.jcrc.2015.10.003. Epub 2015 Oct 27. J Crit Care. 2015. PMID: 26719064 No abstract available.
Abstract
Purpose: Outcomes and risk factors associated with new-onset atrial fibrillation (AF) during acute respiratory distress syndrome (ARDS) are unclear. We investigated mortality and risk factors associated with new-onset AF during ARDS.
Materials and methods: We obtained data from the ARDS Network Albuterol for Treatment of Acute Lung Injury trial, which prospectively identified new-onset AF among patients with ARDS as an adverse event. We determined Acute Physiology and Chronic Health Evaluation III-adjusted associations between new-onset AF and 90-day mortality. We also examined associations between new-onset AF and markers of inflammation (interleukin 6 and interleukin 8), myocardial injury (troponin I), autonomic activation (epinephrine), and atrial stretch (central venous pressure) as well as other clinical characteristics.
Measurements and main results: Of 282 patients (mean age, 51.6 years; 45% women; 77% white) enrolled in Albuterol for Treatment of Acute Lung Injury, 28 (10%) developed new-onset AF during the study. We did not identify associations between new-onset AF and baseline central venous pressure, plasma levels of troponin I, epinephrine, interleukin 6, or interleukin 8. New-onset AF during ARDS was associated with increased 90-day mortality (new-onset AF, 43% vs no new-onset AF, 19%; Acute Physiology and Chronic Health Evaluation-adjusted odds ratio, 3.09 [95% confidence interval, 1.24-7.72]; P = .02).
Conclusion: New-onset AF during ARDS is associated with increased mortality; however, its mechanisms require further study.
Trial registration: ClinicalTrials.gov NCT00434993.
Keywords: Acute respiratory distress syndrome; Atrial fibrillation; Epinephrine; Interleukins; Mechanism; Mortality; Troponin.
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Annane D, Sebille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Bellissant E. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med. 2008;1(178):20–25. - PubMed
-
- Kanji S, Williamson DR, Yghchi BM, Albert M, McIntyre L. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012;326:e1–e8. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical